2013 International Symposium on Hodgkin Lymphoma

Advertisement

Advertisement



Aug
21
Today In Oncology
Detection of Early-Stage Cancers With Ciculating Tumor DNA
Arsenic Trioxide and Reduced Anthracycline Dose in Pediatric Acute Promyelocytic Leukemia
Adding First-Line Selective Internal Radiotherapy to Chemotherapy in Patients With Liver Metastases From Colorectal Cancer
CheckMate-214: Nivolumab and Ipilimumab in Intermediate- and Poor-Risk Previously Untreated Advanced or Metastatic RCC
Crizotinib in Pediatric ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors
Off-the-Shelf, Virus-Specific T Cells for Treating Viral Infections After Transplantation
FDA Approves Olaparib Tablets for Maintenance Treatment in Ovarian Cancer
FDA Approves Inotuzumab Ozogamicin for Relapsed or Refractory B-Cell Precursor ALL
View More 
Advertisement
Most Read Stories
FDA Approves Olaparib Tablets for Maintenance Treatment in Ovarian Cancer
First-Line Cabazitaxel vs Docetaxel in Metastatic Castration-Resistant Prostate Cancer
Partial-Breast and Reduced-Dose Radiotherapy After Breast-Conserving Surgery
Searching for Happiness
ASCO Guideline on Stage IV NSCLC Therapy Updated
KEYNOTE-010 Update Shows ‘Striking’ Durability of Second-Line Pembrolizumab in NSCLC
Surveillance Mammography by Life Expectancy in Older Breast Cancer Survivors
Final Overall Survival Results of GOG 240 Trial Adding Bevacizumab to Chemotherapy in Advanced Cervical Cancer
Genomic Characteristics and Immune Infiltration in Triple-Negative Breast Cancer
CheckMate-214: Nivolumab and Ipilimumab in Intermediate- and Poor-Risk Previously Untreated Advanced or Metastatic RCC
© 2016 HSP News Service, L.L.C.